Predicting the Risk of Patients With Biopsy Gleason Score 6 to Harbor a Higher Grade Cancer

Journal of Urology

Volumn 178, Issue 5, 2007, Pages 1925-1928

  Gofrit, Ofer N ^a   Zorn, Kevin C ^a   Taxy, Jerome B ^a   Lin, Shang ^a   Zagaja, Gregory P ^a   Steinberg, Gary D ^a   Shalhav, Arieh L ^a  

^a Section of Urology   (United States)

Author keywords

biopsy; prostate; prostate specific antigen; prostatectomy; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; PROBABILITY; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; STATISTICAL ANALYSIS; TUMOR VOLUME;

ADENOCARCINOMA; BIOPSY; FOLLOW-UP STUDIES; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 35148823049     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.07.049     Document Type: Article

References (17)

1. Gleason D.F. Histologic grading of prostate cancer: a perspective. Hum Pathol 23 (1992) 273
2. Steinberg D.M., Sauvageot J., Piantadosi S., and Epstein J.I. Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. Am J Surg Pathol 21 (1997) 566
3. Cookson M.S., Fleshner N.E., Soloway S.M., and Fair W.R. Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. J Urol 157 (1997) 559
4. Thickman D., Speers W.C., Philpott P.J., and Shapiro H. Effect of the number of core biopsies of the prostate on predicting Gleason score of prostate cancer. J Urol 156 (1996) 110
5. Bostwick D.G. Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies. Am J Surg Pathol 18 (1994) 796
6. Chun F.K., Briganti A., Graefen M., Montorsi F., Porter C., Scattoni V., et al. Development and external validation of an extended 10-core biopsy nomogram. Eur Urol 49 (2006) 820
7. Epstein J.I. Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made. Am J Surg Pathol 24 (2000) 477
8. King C. Patterns of prostate cancer biopsy grading: trends and clinical implications. Int J Cancer 90 (2000) 305
9. Fleshner N.E., Cookson M.S., Soloway S.M., and Fair W.R. Repeat transrectal ultrasound-guided prostate biopsy: a strategy to improve the reliability of needle biopsy grading in patients with well-differentiated prostate cancer. Urology 52 (1998) 659
10. Ghani K.R., Grigor K., Tulloch D.N., Bollina P.R., and McNeill S.A. Trends in reporting Gleason score 1991 to 2001: changes in the pathologist's practice. Eur Urol 47 (2005) 196
11. D'Amico A.V., Whittington R., Malkowicz S.B., Schultz D., Blank K., Broderick G.A., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 (1998) 969
12. Amin M.B., Grignon D., Bostwick D., Reuter V., Troncoso P., and Ayala A.G. Recommendations for the reporting of resected prostate carcinomas. Association of Directors of Anatomic and Surgical Pathology. Am J Clin Pathol 105 (1996) 667
13. Pinthus J.H., Witkos M., Fleshner N.E., Sweet J., Evans A., and Jewett M.A. Prostate cancers scored as Gleason 6 on prostate biopsy are frequently Gleason 7 tumors at radical prostatectomy: implication on outcome. J Urol 176 (2006) 979
14. Stamey T.A., Kabalin J.N., McNeal J.E., Johnstone I.M., Freiha F., Redwine E.A., et al. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J Urol 141 (1989) 1076
15. Presti Jr. J.C., O'Dowd G.J., Miller M.C., Mattu R., and Veltri R.W. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol 169 (2003) 125
16. Thompson I.M., Pauler D.K., Goodman P.J., Tangen C.M., Lucia M.S., Parnes H.L., et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med 350 (2004) 2239
17. Haggarth L., Busch C., Norberg M., Haggman M., Norlen B.J., and Egevad L. Prediction of the volume of large prostate cancers by multiple core biopsies. Scand J Urol Nephrol 39 (2005) 380